Navigation Links
Bionovo to Present at BMO Capital Markets 2008 Focus on Healthcare Conference
Date:8/4/2008

EMERYVILLE, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective drugs in the areas of women's health and cancer, announced today that Tom Chesterman, SVP and CFO of Bionovo, will be presenting at the BMO Capital Markets 2008 Focus on Healthcare Conference in New York. The presentation is scheduled to begin at 2:15 PM ET on Tuesday, August 5, 2008 at the Millennium Broadway Hotel in New York.

The presentation will be webcast and can be viewed on Bionovo's website at http://webcasts.bionovo.com. A replay of the webcast will become available approximately 24 hours after the presentation ends and will continue to be accessible for twelve months after the event via Bionovo's website.

Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol BNVI. For more information about Bionovo and its programs, visit http://www.bionovo.com.

Forward Looking Statements

'/>"/>
SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
2. Bionovo Announces Proposed Public Offering of Common Stock
3. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Bionovo Announces Third Quarter 2007 Financial Results
6. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
7. George Butler Joins Bionovos Board of Directors
8. Louis Drapeau Joins Bionovos Board of Directors
9. Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness
10. Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
11. Bionovo Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... (PRWEB) October 22, 2014 WriteResult, ... services – has been working with a team of ... New Haven Farms Community Farming Collaborative to provide electronic ... solution. The study, which started in May, aims ... that provides participants weekly exposure to and participation in ...
(Date:10/22/2014)... 2014 Physicians Choice Laboratory Services ... menu, which enables healthcare providers to individualize therapeutic ... evidence-based results, healthcare providers are better able to ... while minimizing risks for adverse drug reactions and ... the FDA [1] more than 2.2 million adverse ...
(Date:10/22/2014)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... Oral Amphotericin B program.  The company recently announced ... work involving samples from HIV/AIDS patients exposed to ... clinical studies and regulatory filings to move forward ... approximately $700,000 of funding and technological advice from ...
(Date:10/22/2014)... DIEGO and HONG KONG ... innovative rare disease therapeutics enterprise, announced today that rare ... the company as vice president, research. Dr. McKew brings ... including key leadership positions at the National Institutes of ... its acquisition by Wyeth). Dr. McKew will lead aTyr,s efforts ...
Breaking Biology Technology:myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
... - Gov. Jim Doyle, during visits to Green Bay and ... production of renewable energy. , ,In what was billed as ... effort to generate 25 percent of electricity and transportation fuel ... energy crisis," Doyle said at Virent Energy Systems ...
... - GE Healthcare , the $15 billion unit ... Translational Genomics Research Institute (TGen), a not-for-profit ... equipment for drug discovery and development. , ,The alliance ... accelerate research in translational genomics, a field that applies ...
... gas pump to the air-conditioning bill, middle class families in ... by the skyrocketing cost of energy. It's simply outrageous that ... car, and Washington continues to allow the oil companies to ... , ,America is facing an energy crisis. It's a crisis ...
Cached Biology Technology:Doyle launches 2025 alternative energy plan 2GE Healthcare partners with genomics institute 2Wisconsin can lead the way to energy independence 2Wisconsin can lead the way to energy independence 3
(Date:10/16/2014)... Respiratory Syncytial Virus causes severe respiratory tract infections ... each year. Scientists at VIB and Ghent University ... to counteract this common virus infection. , ... strategy that paves the way for the development ... a virus that causes suffering in numerous small ...
(Date:10/15/2014)... is a non-traditional biophysics textbook and it describes how ... journey of discovery into biological systems and provides an ... It is about how our genes make proteins that ... of cells in an organism. It quantifies the principles ... can be found on both large and small scales. ...
(Date:10/15/2014)... the 44th Rosenstiel Award for Distinguished Work in Biomedical ... the mechanisms of genomic instability and its implications for ... second alumnus to win the Rosenstiel Award; the first, ... Alt is the Charles A. Janeway Professor of Pediatrics ... an investigator at the Howard Hughes Medical Institute at ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2
... VIEW and LA JOLLA, Calif. Oct. 3, 2011 ... genome sequencing company, and the not-for-profit Scripps Health system ... the Wellderly Study, a landmark scientific research initiative aimed ... Under the collaboration, Complete Genomics will sequence, at its ...
... Playing street football two or three times a week could ... led by the Universities of Exeter and Copenhagen, out today ... the fitness of homeless people, a group with typically poor ... much lower-than-average life expectancy, usually as a result of cardiovascular ...
... type of cancer among women in the United States, ... is key in the treatment of breast cancer and ... arrived at University Hospitals (UH) Case Medical Center ... of the breast. "Tomosynthesis offers women the ...
Cached Biology News:Scripps and Complete Genomics to collaborate on genetic research study on healthy aging 2Scripps and Complete Genomics to collaborate on genetic research study on healthy aging 3Could soccer give homeless men a health kick? 2New technology offers the next generation of mammography 2
... (100+kb), fosmid (40kb), and large plasmid insert ... othe BAC vector. On command 20-50 fold ... recombinant DNA purification. Available with blue-white screening ... for the highest insert stability. Kits include ...
Mouse Exodus 2 - 12kDa...
TGF-beta 2 MAb (Clone 8607)...
Abin-2 (N-16)...
Biology Products: